Indian Pharma Industry Shifts Focus to Innovation After Years of Scale Discussions
The Indian pharmaceutical industry has been discussing a shift from focusing solely on scale to prioritizing innovation and complex therapies for several years. These discussions have become common in policy circles.
The industry’s narrative has evolved to include a greater emphasis on research and development, as well as the production of more sophisticated treatments. This transition reflects a broader ambition to move up the value chain and compete on a global scale through innovation rather than just volume.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: May 6, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]LATEST
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
New Test Detects Biomarkers for Frontotemporal Lobar Degeneration, a Rare Dementia Affecting Over 57 Million Globally
2026-05-10







